BioSpace News Archive

Press Releases

Kapoose Creek Bio Acquires Exclusive License to Adapsyn Bioscience’s World-Leading AI Technology for Drug Development

October 30, 2024
·
3 min read
Press Releases

FDA Grants Orphan Drug Designation to Capsida Biotherapeutics for Potential Treatment of STXBP1 Developmental and Epileptic Encephalopathy

October 30, 2024
·
4 min read
Press Releases

Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics

October 30, 2024
·
8 min read
Press Releases

Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer

October 30, 2024
·
11 min read
Press Releases

OmniAb to Participate in Two Investor Conferences in November

October 30, 2024
·
2 min read
Press Releases

Astria Therapeutics to Present at Upcoming Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting

October 30, 2024
·
1 min read
Press Releases

Alterome Therapeutics Announces First Patient Dosed in Phase 1 Study of ALTA2618 in AKT1 E17K-mutant solid tumors (AKTive-001)

October 30, 2024
·
2 min read
Press Releases

UroGen Pharma to Report Third Quarter Financial Results on Wednesday, November 6, 2024

October 30, 2024
·
1 min read
Press Releases

Myriad Genetics to Release Third Quarter 2024 Financial Results on November 7, 2024

October 30, 2024
·
1 min read
Press Releases

Noema Pharma Announces First Patients Dosed in Phase 2b Study with Gemlapodect (NOE-105), a First-In-Class Investigational Therapy for Tourette Syndrome

October 30, 2024
·
2 min read